ProfoundBio’s Post

View organization page for ProfoundBio, graphic

3,911 followers

Excited to share ProfoundBio will be acquired by Genmab—this is a big step in our journey to make a positive impact for patients with #cancer through our novel ADC technology and pipeline.

View organization page for Genmab, graphic

107,320 followers

News Update: Genmab to broaden and strengthen its oncology portfolio with the acquisition of ProfoundBio.   Jan van de Winkel, Ph.D., President & CEO shares how the proposed acquisition of ProfoundBio, a biotechnology company focused on the development of novel antibody-drug conjugate (ADC) based therapies, will propel Genmab towards its ambitious 2030 vision to transform patients’ lives with KYSO® (Knock-your-socks-off) antibody medicines. Learn more at: https://lnkd.in/erzmStPB #News #Biotech #Oncology

Ben Batten

Linkedin Top Voice | CEO & Founder at Eureka | Recruitment | Talent strategy | Career expert | SIA 'Staffing 100' Leader

6mo

Huge new indeed!

Like
Reply
Jing Yang

Clinical Development Clin Pharm

7mo

Congratulations Baiteng Zhao Tae Han Xiao Shang !

Lorna Damo

Associate Director Senior Scientist at Denali Therapeutics

6mo

Congrats to Baiteng Zhao Tae Han Xiao Shang! Such a humongous feat!

Like
Reply
Emily Larsen

Biotechnology Leader and Entrepreneur

7mo

Congratulations!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics